How Long Does Wegovy Take to Curb Appetite — and What to Expect

Early appetite changes can appear within days to a few weeks of the first injection, but are typically modest at the starting dose.
The appetite-suppressing effect strengthens with each dose step — most people reach the 2.4mg maintenance dose after around 16–20 weeks of titration.
Clinical trial participants on semaglutide 2.4mg lost an average of around 15% of body weight over 68 weeks, reflecting how the appetite effect compounds over time.
If appetite suppression feels negligible after several months at your highest tolerated dose, that is a conversation for your prescriber, not a reason to increase the dose yourself.

Most people notice Wegovy beginning to curb appetite within the first one to four weeks of starting treatment, though the degree of suppression builds gradually over months as the dose increases. Semaglutide works on GLP-1 receptors that regulate hunger signals in the brain, so the effect is progressive rather than immediate. These are prescription-only medicines; a prescriber assesses whether they are clinically appropriate for you before treatment begins.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The timeline, the titration, and why patience is the actual mechanism

The myth: Wegovy switches off hunger from injection one

The most common misconception is that semaglutide works like a light switch. People expect to wake up the morning after their first 0.25mg injection with no interest in food whatsoever. That is not how it works, and understanding why makes the real timeline much easier to manage.

The 0.25mg starting dose is a tolerability step. Its job is to let your body adjust to the medicine, not to deliver the full appetite effect. Most people at this stage notice a modest reduction in how hungry they feel between meals, or find they feel full a little sooner than usual. Some notice nothing for the first week or two. Both responses are normal.

The hunger-regulation pathway that semaglutide acts on involves GLP-1 receptors in the hypothalamus and gut. Slowing gastric emptying and signalling fullness to the brain are both part of the picture. Those effects are real from the first dose, but they become meaningfully stronger as the dose increases through the titration schedule. The Wegovy treatment overview covers how the titration schedule is structured and what each stage involves.

When most people actually feel a difference, dose by dose

The licensed titration pathway runs from 0.25mg up through 0.5mg, 1.0mg and 1.7mg to the 2.4mg maintenance dose, with roughly four weeks at each level. For most people, how quickly semaglutide reduces appetite becomes clearer somewhere in the 0.5mg to 1.0mg range, usually six to twelve weeks in, when suppression grows noticeably stronger. By 1.7mg and 2.4mg, the effect is at its most pronounced for the majority of patients.

This matters practically. If you start Wegovy expecting a dramatic change in the first fortnight and feel little, the temptation is to conclude it is not working. For most people, the medicine is working exactly as it should, settling your system before the dose that actually changes your appetite arrives a few weeks later. The full breakdown of how long Wegovy takes to work covers weight-loss timelines as well as appetite, if you want the broader picture.

One practical note: many people find it useful to do their weekly injection on the same day each week (Sunday evening, say) so the rhythm becomes automatic before the full effects are felt. That consistency matters more than it might seem.

The STEP 1 trial, published in the New England Journal of Medicine, followed 1,961 adults on semaglutide 2.4mg over 68 weeks. Average weight loss was around 15% of body weight. Those results reflect sustained appetite suppression built up over the full titration period, not a single-dose effect.

Individual variation: why your timeline may differ from someone else's

Appetite suppression from semaglutide varies between people, and that variation is genuine rather than a sign that treatment has failed. Factors that influence how quickly and strongly the effect is felt include metabolic rate, the composition of meals (fat and protein slow gastric emptying further, amplifying satiety), and how sensitive an individual's GLP-1 receptors are.

Gastrointestinal side effects (nausea, early fullness, mild reflux) can make appetite suppression feel more pronounced in the early weeks simply because eating feels uncomfortable. This is not the same as the therapeutic effect. As the GI symptoms settle, usually over a few weeks, the appetite effect that remains is the actual pharmacological one. The NHS semaglutide medicines page has a plain-English summary of what to expect and when to seek help.

If you are thinking about what happens to appetite after stopping Wegovy, that is a separate and important question, appetite does tend to return once treatment stops, which is why the medicine is used as part of an ongoing plan.

Questions about your own response (whether your appetite suppression feels too weak, too strong, or accompanied by symptoms that worry you) belong with your prescriber. Our team is available seven days a week for aftercare queries once you are on treatment.

Cost, access, and whether a private prescription makes sense

Wegovy is a prescription-only medicine, so the route to starting it always involves a clinical assessment. On the NHS, access is through specialist weight management services and waiting times can be substantial. How quickly semaglutide suppresses appetite is a separate question from how quickly you can access treatment, for many people, the private route removes that second waiting period entirely.

If you are weighing up the cost, the Wegovy pricing page explains what an all-in private prescription includes and how to read a headline price honestly. The right question for a prescription medicine is never just what it costs, it is what the price actually covers.

For a fuller comparison of semaglutide and tirzepatide on appetite and weight outcomes, the weight-loss treatment overview sets out the evidence side by side.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions